Melanoma occurring during treatment with fingo… [Arch Dermatol. 2011] – PubMed – NCBI

Posted on January 16, 2013 by Maurice Preter MD

Arch Dermatol. 2011 Aug;147(8):991-2. doi: 10.1001/archdermatol.2011.212. Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report. Conzett KB, Kolm I, Jelcic I, Kamarachev J, Dummer R, Braun R, French LE, Linnebank M, Hofbauer GF. PMID: 21844470 [PubMed – … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, new treatments, Psychiatry/Neurology | Tagged , , , , |

Delayed fingolimod-associated asystole. [Mult Scler. 2011] – PubMed – NCBI

Posted on January 16, 2013 by Maurice Preter MD

Mult Scler. 2011 Nov;17(11):1387-9. doi: 10.1177/1352458511410344. Epub 2011 Jun 7. Delayed fingolimod-associated asystole. Espinosa PS, Berger JR. Source North Oaks Neurology, Hammond, LA, USA. ps.espinosa@gmail.com Abstract Oral fingolimod (Gilenya) is a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, keto, new treatments, Psychiatry/Neurology | Tagged , , |

25-Hydroxyvitamin D, dementia, and cerebrovascular… [Neurology. 2010] – PubMed – NCBI

Posted on January 15, 2013 by Maurice Preter MD

Neurology. 2010 Jan 5;74(1):18-26. doi: 10.1212/WNL.0b013e3181beecb7. Epub 2009 Nov 25. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, Bergethon P, Rosenberg IH, Folstein MF, Patz … Continue reading →

Posted in Fifth Avenue Concierge Medicine, keto, Psychiatry/Neurology | Tagged , , , |

Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.

Posted on January 15, 2013 by Maurice Preter MD

Lancet Neurol. 2011 May;10(5):436-45. doi: 10.1016/S1474-4422(11)70045-X. Epub 2011 Mar 31. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Banwell B, Bar-Or A, Arnold DL, Sadovnick D, Narayanan S, McGowan M, … Continue reading →

Posted in Fifth Avenue Concierge Medicine, keto, Psychiatry/Neurology | Tagged , , |

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

Posted on January 15, 2013 by Maurice Preter MD

J Neurol Neurosurg Psychiatry. 2012 May;83(5):565-71. doi: 10.1136/jnnp-2011-301876. Epub 2012 Feb 22. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis. Soilu-Hänninen M, Aivo J, Lindström … Continue reading →

Posted in Fifth Avenue Concierge Medicine, keto, Psychiatry/Neurology | Tagged , , |